These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8040289)

  • 1. Early and specific antibody response to OspA in Lyme Disease.
    Schutzer SE; Coyle PK; Dunn JJ; Luft BJ; Brunner M
    J Clin Invest; 1994 Jul; 94(1):454-7. PubMed ID: 8040289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
    Schutzer SE; Coyle PK; Krupp LB; Deng Z; Belman AL; Dattwyler R; Luft BJ
    J Clin Invest; 1997 Aug; 100(4):763-7. PubMed ID: 9259573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early OspA immune complex formation in animal models of Lyme disease.
    Schutzer SE; Luan J
    J Mol Microbiol Biotechnol; 2003; 5(3):167-71. PubMed ID: 12766346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.
    Kalish RA; Leong JM; Steere AC
    Infect Immun; 1995 Jun; 63(6):2228-35. PubMed ID: 7768602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.
    Vaz A; Glickstein L; Field JA; McHugh G; Sikand VK; Damle N; Steere AC
    Infect Immun; 2001 Dec; 69(12):7437-44. PubMed ID: 11705918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
    Kalish RA; Leong JM; Steere AC
    Infect Immun; 1993 Jul; 61(7):2774-9. PubMed ID: 7685738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME; Roberge J; Carbonaro CA; Nowakowski J; Nadelman RB; Wormser GP
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity.
    Foley DM; Wang YP; Wu XY; Blanco DR; Lovett MA; Miller JN
    J Clin Invest; 1997 Apr; 99(8):2030-5. PubMed ID: 9109448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Lyme disease after OspA vaccine.
    Schutzer SE; Luan J; Coyle PK
    N Engl J Med; 1997 Sep; 337(11):794-5. PubMed ID: 9289653
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.
    Magni R; Espina BH; Shah K; Lepene B; Mayuga C; Douglas TA; Espina V; Rucker S; Dunlap R; Petricoin EF; Kilavos MF; Poretz DM; Irwin GR; Shor SM; Liotta LA; Luchini A
    J Transl Med; 2015 Nov; 13():346. PubMed ID: 26537892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
    J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
    Krause A; Burmester GR; Rensing A; Schoerner C; Schaible UE; Simon MM; Herzer P; Kramer MD; Wallich R
    J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.
    Rauer S; Spohn N; Rasiah C; Neubert U; Vogt A
    J Clin Microbiol; 1998 Apr; 36(4):857-61. PubMed ID: 9542898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.
    Akin E; McHugh GL; Flavell RA; Fikrig E; Steere AC
    Infect Immun; 1999 Jan; 67(1):173-81. PubMed ID: 9864212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.
    Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM
    Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.